What are the opening hours?

Monday 09:00 - 17:00 Tuesday 09:00 - 17:00 Wednesday 09:00 - 17:00 Thursday 09:00 - 17:00 Friday 09:00 - 17:00

Cuprina Wound Care Solutions

Home
Singapore
Singapore
Cuprina Wound Care Solutions

Developed in 2008, and re-launched in 2019, Cuprina Pte Ltd is a Singapore headquartered medical device manufacturing and distribution company.

We specialize in the manufacture of MEDIFLI, a biological debridement product.

05/09/2025

Reimagining Wound Healing with Amphibian-Derived Innovation

Chronic wounds demand more than conventional care. At Cuprina, we’ve developed a biologically advanced solution to meet the challenge.

Introducing ANURAN SP1 — a next-generation collagen sponge dressing made from native Type I bullfrog collagen. Engineered to accelerate healing post-debridement, ANURAN SP1 provides a microporous scaffold that manages exudate, reduces inflammation, and supports granulation — guiding wounds toward closure.

With superior biocompatibility, tensile strength, and thermostability, ANURAN SP1 is more than a dressing — it’s a platform for regenerative recovery.

The future of wound care is amphibian-powered. https://cuprina.com/discover-anuran-collagen

08/08/2025

Healing the Future: Trends Reshaping Wound Care

As the wound care industry shifts toward advanced, personalized, and biologically driven solutions, Cuprina is proud to be at the forefront of this transformation.

This recent industry overview, “Healing the Future: Trends Driving the Wound Care Market”, highlights the rising demand for modern approaches to managing chronic wounds — a demand fueled by aging populations, diabetes prevalence, and the need for cost-effective, patient-centered care.

At Cuprina, we address this need through MEDIFLY®, our clinically proven maggot debridement therapy. By leveraging nature’s precision and science-backed efficacy, MEDIFLY is actively helping reduce amputation rates and eliminate infections in chronic wounds across hospitals in Singapore and Hong Kong.

From biologics to smart wound technologies, the future of wound care is one of innovation — and we’re proud to contribute to that future every day. Check out the article here: https://vocal.media/journal/healing-the-future-trends-driving-the-wound-care-market

24/07/2025

This week, Cuprina Wound Care Solutions ( CUPR) had the pleasure of hosting students from St. Paul’s Co-educational College, Hong Kong, at our lab in Singapore as part of their STEM school trip.

It was a meaningful opportunity to connect with the next generation of scientists and innovators, sharing insights into our biomedical research and development work. Their curiosity and enthusiasm made for an inspiring visit!

03/07/2025

Your skin trains with you. It deserves to recover with you.

Introducing MEND Skin Restoration Balm—Cuprina’s high-performance skincare formula designed for athletes, outdoor warriors, and everyday skin strugglers. Infused with collagen, hydroxyethyl urea, and natural plant extracts, MEND isn’t just hydration—it’s resilience in a jar.

From Singapore’s gyms to the trails of Australia, MEND is fueling skin recovery where the grind never stops. Whether you’re cycling in humidity or lifting in dry air, MEND restores the barrier, so your skin stays as strong as your goals.

📍Available now across Singapore, Malaysia, and Australia. Because peak performance starts at the surface. https://cuprina.com/mend-skin-restoration-balm

24/06/2025

The global healthcare landscape is increasingly recognizing the value of integrative and holistic approaches to patient care. In May 2025, the World Health Organization (WHO) launched its first-ever Traditional, Complementary, and Integrative Medicine (TCIM) dashboards, providing dynamic, real-time data to support evidence-based policymaking and strengthen global collaboration in this field.

Our MEDIFLY bio-dressing employs Maggot Debridement Therapy (MDT) to effectively disinfect and debride chronic wounds, while our upcoming bullfrog collagen dressings aim to support the body’s natural healing processes.

By integrating traditional wisdom with modern medical innovation, we strive to offer comprehensive care solutions that address the multifaceted needs of patients, particularly those with chronic wounds. Check out the article here: https://www.who.int/news/item/21-05-2025-who-unveils-groundbreaking-global-dashboards-for-traditional—complementary-and-integrative-medicine?

13/06/2025

The global diabetes epidemic continues to escalate, with projections indicating a 59.7% increase in prevalence between 2021 and 2050, rising from 6.1% to 9.8% of the global population. This surge underscores the urgent need for effective management strategies to mitigate associated complications, such as diabetic foot ulcers.

Cuprina Wound Care Solutions (Nasdaq: CUPR) is committed to addressing this challenge through innovative wound care solutions. Our MEDIFLY bio-dressing utilizes Maggot Debridement Therapy (MDT) to effectively disinfect and debride chronic wounds, reducing the risk of infections and amputations. Additionally, our research into collagen wound dressings derived from bullfrog skin has shown promising results in accelerating wound healing.

By focusing on advanced, nature-inspired therapies, we aim to improve outcomes for individuals affected by diabetes-related complications, contributing to global efforts in managing this growing health concern. Check out the article here: https://www.pharmacytimes.com/view/study-prevalence-of-diabetes-expected-to-increase-by-59-7-in-2025?

11/04/2025

We’re officially live on

Today marks a historic milestone: Cuprina is officially a publicly traded company under ticker Nasdaq: CUPR.

As a Singapore-based MedTech innovator, our mission has always been to bring science-backed, life-changing wound care to patients in need. Our flagship product MEDIFLY — a live, medical-grade maggot bio-dressing — is already transforming treatment outcomes for chronic wounds across Singapore and Hong Kong.

From hospital wards to the global markets, we’re just getting started.

20/09/2024

Individuals with diabetes are up to 39 times more likely to face the possibility of amputation compared to those without the condition. With 70% of all leg amputations occurring in people with diabetes worldwide, the need for effective wound care solutions has never been more urgent.

At Cuprina, we’re dedicated to providing innovative solutions that can help preserve quality of life and avoid unnecessary amputations. Our MEDIFLY product is at the forefront of this mission, offering a groundbreaking approach to wound healing. Clinical data reveals a limb salvage rate of 90.9% and a wound closure rate of 45.5% in challenging patient populations.

In Singapore, where the rate of lower extremity amputations is alarmingly high, with approximately four procedures conducted daily in public hospitals, the need for alternative treatments is critical.

We understand that Maggot Therapy might be a novel concept for some, but it’s essential to explore all effective wound care options. Learn more about MEDIFLY by visiting our website: https://cuprina.com/

09/08/2024

At Cuprina, our journey started with the vision of our Co-Founder, Carl Baptista. With a background in Biotechnology and Applied Entomology, Carl’s passion for harnessing biological solutions to tackle global challenges has been unwavering. His career began in pest control, where he discovered the untapped potential of insects in various industries.

This passion led Carl to explore medical applications of insects, particularly maggot debridement therapy for chronic wound care. Driven by the desire to enhance existing treatments, Cuprina Wound Care Solutions was born. Today, we continue Carl’s mission to revolutionize wound care with innovative, insect-based solutions.

Learn more about Cuprina here: https://cuprina.com/story

22/07/2024

Last week, we had the pleasure of hosting a group of bright students from St. Paul’s Co-educational College (聖保羅男女中學) and Yu Chun Keung Memorial College No.2 (余振強紀念第二中學) in Hong Kong for an exciting STEM school trip at our Singapore lab.

Carl Baptista and our Cuprina Wound Care Solutions team were thrilled to share our advancements and inspire these young minds. The future of MedTech looks promising with such passionate and curious students!

01/07/2024

We recently had the pleasure of hosting a group of bright young minds from Queen Elizabeth School Old Students’ Association Primary School (伊利沙伯中學舊生會小學) in Hong Kong at our Singapore lab! This STEM school trip was a fantastic success, showcasing Cuprina Wound Care Solutions dedication to promoting STEM education and fostering international collaboration. 🌏🔬

The students were highly engaged and enthusiastic as they learned about the science behind insects and how Cuprina has harnessed the power of nature to develop MEDIFLY, our bio-dressing made of live, medical-grade maggots. MEDIFLY is utilized by private and public hospitals in Singapore and Hong Kong for Maggot Debridement Therapy (MDT), disinfecting and debriding chronic wounds. 🏥🦟

A big thank you to Carl Baptista Bapitsta, our founder and CTO, and Chee Yuan Moo, our entomologist, for being our main speakers and inspiring the next generation of scientists. Your passion and expertise truly made the visit unforgettable.

We’re proud to contribute to STEM education and look forward to more opportunities to engage with young learners worldwide! 🌍📚

https://cuprina.com/

29/05/2024

Maggot debridement therapy (MDT) has long been recognized for its efficacy in promoting wound healing through debridement, disinfection, and growth-promoting activity. Despite its extensive use in the UK, MDT remains an underutilized modality in many wound care markets.
sg is proud to be at the forefront of this transformative approach to wound care. Our flagship product, MEDIFLY, harnesses the power of live, medical-grade maggots to disinfect and debride chronic wounds. Trusted by both private and public hospitals in Singapore and Hong Kong, is making waves in the field of Maggot Debridement Therapy.

As the prevalence of chronic diabetic foot wounds rises, the importance of effective wound management cannot be overstated. That’s why our team at Cuprina is dedicated to developing cutting-edge solutions to address the complex challenges faced by healthcare professionals.

Check out the full publication for a comprehensive overview of the research evidence surrounding MDT, and discover how Cuprina is leading the way in revolutionizing wound care. https://pubmed.ncbi.nlm.nih.gov/25478859/

Address

Singapore

Opening Hours

Monday	09:00 - 17:00
Tuesday	09:00 - 17:00
Wednesday	09:00 - 17:00
Thursday	09:00 - 17:00
Friday	09:00 - 17:00

Website

http://www.cuprina.com/

Alerts

Be the first to know and let us send you an email when Cuprina Wound Care Solutions posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Cuprina Wound Care Solutions:

Shortcuts

Featured

The Prenatal Consultants
101 Irrawaddy Road, #15-05/06 Royal Square Medical Centre

Want your practice to be the top-listed Clinic in Singapore?